BIXT
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
May 2 closing price
Capitalization
13.61M
DOMH
Price
$5.66
Change
+$0.56 (+10.98%)
Updated
May 2 closing price
Capitalization
82.88M
9 days until earnings call
Ad is loading...

BIXT vs DOMH

Header iconBIXT vs DOMH Comparison
Open Charts BIXT vs DOMHBanner chart's image
Bioxytran
Price$0.15
Change-$0.00 (-0.00%)
Volume$15.16K
Capitalization13.61M
Dominari Holdings
Price$5.66
Change+$0.56 (+10.98%)
Volume$479.7K
Capitalization82.88M
BIXT vs DOMH Comparison Chart
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. DOMH commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and DOMH is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (BIXT: $0.15 vs. DOMH: $5.66)
Brand notoriety: BIXT and DOMH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 5% vs. DOMH: 97%
Market capitalization -- BIXT: $13.61M vs. DOMH: $82.88M
BIXT [@Biotechnology] is valued at $13.61M. DOMH’s [@Biotechnology] market capitalization is $82.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileDOMH’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • DOMH’s FA Score: 0 green, 5 red.
According to our system of comparison, DOMH is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 4 TA indicator(s) are bullish while DOMH’s TA Score has 4 bullish TA indicator(s).

  • BIXT’s TA Score: 4 bullish, 3 bearish.
  • DOMH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than DOMH.

Price Growth

BIXT (@Biotechnology) experienced а -5.53% price change this week, while DOMH (@Biotechnology) price change was +18.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.14%. For the same industry, the average monthly price growth was +19.88%, and the average quarterly price growth was -5.87%.

Reported Earning Dates

DOMH is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+6.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DOMH($82.9M) has a higher market cap than BIXT($13.6M). DOMH YTD gains are higher at: 498.318 vs. BIXT (70.345). BIXT has higher annual earnings (EBITDA): -2.67M vs. DOMH (-14.1M). DOMH has more cash in the bank: 49.7M vs. BIXT (34.7K). BIXT has less debt than DOMH: BIXT (934K) vs DOMH (3.15M). DOMH has higher revenues than BIXT: DOMH (12.6M) vs BIXT (0).
BIXTDOMHBIXT / DOMH
Capitalization13.6M82.9M16%
EBITDA-2.67M-14.1M19%
Gain YTD70.345498.31814%
P/E RatioN/AN/A-
Revenue012.6M-
Total Cash34.7K49.7M0%
Total Debt934K3.15M30%
FUNDAMENTALS RATINGS
BIXT vs DOMH: Fundamental Ratings
BIXT
DOMH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DOMH's Valuation (63) in the null industry is in the same range as BIXT (85). This means that DOMH’s stock grew similarly to BIXT’s over the last 12 months.

DOMH's Profit vs Risk Rating (100) in the null industry is in the same range as BIXT (100). This means that DOMH’s stock grew similarly to BIXT’s over the last 12 months.

DOMH's SMR Rating (100) in the null industry is in the same range as BIXT (100). This means that DOMH’s stock grew similarly to BIXT’s over the last 12 months.

DOMH's Price Growth Rating (34) in the null industry is in the same range as BIXT (37). This means that DOMH’s stock grew similarly to BIXT’s over the last 12 months.

DOMH's P/E Growth Rating (100) in the null industry is in the same range as BIXT (100). This means that DOMH’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTDOMH
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 25 days ago
84%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBUY63.271.79
+2.91%
Amplify Online Retail ETF
EWQ41.860.79
+1.92%
iShares MSCI France ETF
QUS156.131.95
+1.26%
SPDR® MSCI USA StrategicFactors ETF
CTEX17.36N/A
N/A
ProShares S&P Kensho Cleantech ETF
XHYC35.78N/A
N/A
BondBloxx US HY Cnsmr Cyclcls Sctr ETF

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+2.09%
CCCC - BIXT
22%
Poorly correlated
+6.75%
IMUX - BIXT
22%
Poorly correlated
-1.71%
WVE - BIXT
20%
Poorly correlated
+2.02%
DOMH - BIXT
20%
Poorly correlated
+10.98%
BSEM - BIXT
11%
Poorly correlated
+0.50%
More

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with EDSA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
+10.98%
EDSA - DOMH
37%
Loosely correlated
+0.17%
AXON - DOMH
36%
Loosely correlated
+1.14%
FHTX - DOMH
34%
Loosely correlated
+1.92%
MBRX - DOMH
31%
Poorly correlated
+1.98%
ARDX - DOMH
31%
Poorly correlated
-24.50%
More